Cabergoline Treatment of hyperprolactinemia
Treatment of hyperprolactinemia, either idiopathic or due to pituitary adenomas.
1 Specification
HP9017 Cabergoline EP5.0 CAS81409-90-7 Fresh stock | ||
Cabergoline | CAS 81409-90-7 | Brand: Hyper |
MW: 451.60 | MSDS: Avaiable | |
MF : C26H37N5O2 | Sample: Avaiable | |
Category:Raw materials | Min order: 10grams | |
Quality standard : EP5.0 | Place of Origin:China | |
Introduction | Treatment of hyperprolactinemia, either idiopathic or due to pituitary adenomas. Investigational: Shrink tumors in clients with microprolactinoma or macroprolactinoma. Parkinson's disease. Normalize androgen levels and improve menstrual cyclicity in polycystic ovary syndrome. | |
Storage and Transport conditions | Sealed in shade ( +2-+8 °C) | |
Applications | Pharmaceutical raw materials |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View